Category archive
Browse every WeightEasy article in the New Drugs category.
Category pages gather broader article themes, which makes them useful for readers who are exploring a whole area like injection routines, side effects, or dose tracking rather than a single narrow question.
If your doctor has mentioned Obeda as a weight loss or diabetes treatment option, you are looking at one of the newest GLP 1 medicines to reach Indian pharmacies. Dr. Reddy's Labor...
CagriSema is Novo Nordisk's most ambitious new obesity drug. It combines two separate hormone targeting mechanisms in a single weekly injection and Phase 3 data shows it significan...
The GLP 1 drug landscape is changing faster in 2026 than in any previous year. Two drugs are already in FDA review, one approved yesterday, and others with extraordinary trial data...
If your doctor has just prescribed Noveltreat, or if you have heard about it and want to know more, you are not alone. A lot of people feel a little confused when they first hear w...
Orforglipron is the most anticipated new GLP 1 drug of 2026. Developed by Eli Lilly, it is a once daily oral pill with no injection and no fasting requirements a combination that d...
Retatrutide is the drug that may redefine how the medical world thinks about weight loss. In one Phase 3 clinical trial, participants lost an average of 71.2 lbs (32.3 kg) over 68...
If your doctor has recently prescribed Semaglyn, you may be wondering how this injection works and whether it is right for you. That is completely normal. New medicines can feel co...
Something historic happened in India's pharmaceutical market today. On March 20, 2026, the patent on semaglutide the active ingredient in Ozempic and Wegovy expired. Overnight, ove...
Generic semaglutide arrived in India on March 20, 2026. Among the 50+ brands entering the market on patent expiry day, Sun Pharma's Sematrinity is the headline launch and for anyon...
Wegovy HD received FDA approval on March 19, 2026. It is a higher dose formulation of the same semaglutide injection that has been available since 2021, but at 7.2 mg rather than t...
Wegovy pill was FDA approved on December 22, 2025. It is the first oral GLP 1 medication approved specifically for weight loss in adults, making it a significant option for people...